Our experts
We are committed to reliable, high-quality work and to supporting researchers, clinicians, and other partners every step of the way.
About our team
Our team combines a broad range of expertise needed to bring cell and gene therapies and challenge agents safely from the laboratory to the patient. Together we cover pharmacy, GMP manufacturing, quality assurance, quality control, regulatory affairs, and process development. This means that within one team we can develop a manufacturing process, produce a product under GMP conditions, test it, and prepare it for use in clinical trials.
Many of our team members have years of experience in their field, and we work in close collaboration so that knowledge is shared across disciplines. We collaborate with research groups within the hospital, and with academic and other partner groups both nationally and internationally (e.g. DARE-NL, ReNEW, MuSICC, CORE-ATMP, IMPACT, P-SMART). Because cell and gene therapy is a fast-moving field, we invest continuously in training and education. Team members are trained for their specific tasks and regularly update their knowledge and skills, so that we maintain high-quality, up-to-date services.
Pauline Meij, PhD
Head of CCG
Qualified Person
Eileen van der Stoep, PharmD, PhD
Hospital Pharmacist
Qualified Person
Deputy head
Inge van Amerongen-Westra, PhD
Qualified Person
QC lead
Helene Roelofs, PhD
Qualified Person
Fong Lin, MSc
Research technician
Susanne Kortekaas, MSc
Projectmanager / QA
Natascha Fonseca Neves
Research technician
Mara Tihaya, MD
Researcher CMC development and regulation
Pim Schipper, PhD
Researcher CMC development and regulation
Gonzalo Mullen
Research technician
Vladimir van Hoek
Research technician
Chris Maddocks, PhD
Researcher CMC development and regulation
Akvilė Gasiūnaitė, MSc
PhD student
Nina Nooteboom, MSc
PhD student
Thijs Rietveld, MSc
PhD student